ABOS short interest
Acumen Pharmaceuticals Inc. · Healthcare · Biotechnology · settlement date 2026-09-30
| Shares short | 3,079,512 |
|---|---|
| Change vs prior report | 275,368 (+9.8%) |
| Change over six months | +191.8% |
| Days to cover | 4.80 (sector: 3.78) |
| Average daily volume | 641,518 |
| Rank in Healthcare | #436 of 922 by days to cover |
ABOS short interest, last 12 months
| Settlement | Shares short | Change | Days to cover | Avg daily volume |
|---|---|---|---|---|
| 2026-09-30 | 3,079,512 | +9.8% | 4.80 | 641,518 |
| 2026-09-15 | 2,804,144 | -11.3% | 8.16 | 343,829 |
| 2026-08-31 | 3,163,185 | -1.9% | 8.24 | 384,006 |
| 2026-08-14 | 3,225,089 | -4.2% | 10.40 | 310,001 |
| 2026-07-31 | 3,367,011 | +19.6% | 9.46 | 355,781 |
| 2026-07-15 | 2,814,458 | +0.9% | 7.51 | 374,875 |
| 2026-06-30 | 2,788,975 | +47.8% | 2.60 | 1,071,385 |
| 2026-06-15 | 1,886,963 | -0.3% | 5.87 | 321,419 |
| 2026-05-29 | 1,892,556 | +8.3% | 5.49 | 344,819 |
| 2026-05-15 | 1,747,125 | +4.2% | 6.39 | 273,487 |
| 2026-04-30 | 1,675,956 | +8.5% | 5.17 | 324,098 |
| 2026-04-15 | 1,545,029 | +46.4% | 3.08 | 501,254 |
| 2026-03-31 | 1,055,415 | +2.3% | 1.00 | 1,232,212 |
| 2026-03-13 | 1,032,017 | +7.4% | 3.10 | 332,656 |
| 2026-02-27 | 960,875 | +1.4% | 3.60 | 266,694 |
| 2026-02-13 | 947,292 | +5.2% | 2.35 | 403,959 |
| 2026-01-30 | 900,167 | +50.1% | 1.00 | 2,325,666 |
| 2026-01-15 | 599,667 | +8.3% | 2.56 | 233,792 |
| 2025-12-31 | 553,811 | -2.5% | 3.00 | 184,784 |
| 2025-12-15 | 568,193 | -1.2% | 4.01 | 141,816 |
| 2025-11-28 | 575,361 | -56.4% | 3.50 | 164,527 |
| 2025-11-14 | 1,318,100 | -4.1% | 6.96 | 189,378 |
| 2025-10-31 | 1,374,712 | +3.1% | 4.06 | 338,237 |
| 2025-10-15 | 1,332,676 | +1.6% | 2.63 | 505,996 |
| 2025-09-30 | 1,311,722 | -3.3% | 2.65 | 494,348 |
import finzdata as yf
yf.Ticker("ABOS").short_interest # every report since 2017
yf.Client().short_interest(["ABOS"], start="2018-01-01")Healthcare short interest · ABOS price history · Who owns ABOS · All short interest